PuraPly


In chronic wounds, unmanaged bioburden can progress to biofilm, which is challenging and often unresponsive to conventional treatment

•  Biofilm can adversely affect tissue repair and delay healing1,2
•  Biofilm can re-form within 24 hours following debridement3
•  Topical antimicrobials, such as silver, have demonstrated cytotoxic effects associated with delayed healing4,5
•  Systemic antibiotics can fail to reach adequate levels in localized tissue6


Now there is a novel technology to manage bioburden while supporting healing: PuraPly™ Antimicrobial (AM), the first purified collagen matrix with PHMB*7

Provides clinical benefits in 3 ways:

1.  Purified Type I collagen matrix creates a durable, biocompatible scaffold8
2.  Effective barrier against a wide range of microorganisms2,8
3.  PHMB is known to disrupt and inhibit the formation of biofilm on the wound surface2
*PHMB = polyhexamethylenebiguanide hydrochloride.


Learn how PuraPly™ AM is changing the way some clinicians practice wound care

"Not only does [PuraPly™] assist in healing because of purified collagen, it assists in the eradication of the bioburden and stopping the progression from a colonized to a critically colonized wound environment to support healing."
Jeffrey C. Karr, DPM
Karr Foot and Leg Center
Lakeland, FL


For more information, visit us at Booth 200 at the Symposium for Advanced Wound Care Conference, September 26-28


PuraPly™ Antimicrobial (AM): Manage a wide variety of wounds.
Shield against microbes.


www.puraplyam.com


References:
1.
 Mulder GD, Carvosi JP, Lee DK. Wounds. 2007;19(7):173-182. 2. Hubner NO, Kramer A. Skin Pharmacol Physiol. 2010;23(suppl):17-27. 3. Wolcott R, Cutting KF, Ruiz JC. Association for the Advancement of Wound Care. Publication No. UKCT-A0021. 2008:12-17. 4. Zou SB, Yoon WY, Han SK, Jeong SH, Cui ZJ, Kim WK. Int Wound J. 2013;10(3):306-312. 5. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Cochrane Database Syst Rev. 2010;(3):CD006478. 6.Leaper D, Snyder RJ. Association for the Advancement of Wound Care. Publication No. UKCT-A0021. 2008:5-9. 7. PuraPly Antimicrobial [package insert]. Canton, MA: Organogenesis Inc; 2015. 8. Data on file. Organogenesis Inc.


©2015 Organogenesis Inc. OI-A1195 09-2015. All rights reserved. PuraPly Antimicrobial and PuraPly are trademarks of Organogenesis Inc. Please see complete prescribing information at www.organogenesis.com.